PPA
KRRO icon

Parametric Portfolio Associates’s Korro Bio KRRO Stock Holding History

Parametric Portfolio Associates’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$154K Sell
1,454
-222
-13% -$42.4K ﹤0.01% 3495
2021
Q4 		$430K Buy
1,676
+24
+1% +$7.29K ﹤0.01% 3124
2021
Q3 		$583K Buy
1,652
+729
+79% +$287K ﹤0.01% 3032
2021
Q2 		$460K Buy
923
+703
+320% +$343K ﹤0.01% 3121
2021
Q1 		$104K Buy
+220
New +$427K ﹤0.01% 3962

Other funds holding KRRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Parametric Portfolio Associates's KRRO Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Korro Bio (KRRO) stake by 13% in Q1 2022, selling an estimated $42.4K and leaving 1,454 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #3495.

Parametric Portfolio Associates first reported a position in KRRO in Q1 2021 and has held it in 5 quarters since. The position peaked at $583K in Q3 2021. 85 funds tracked by Wall St. Rank hold KRRO as of Q1 2022.

  • Parametric Portfolio Associates held 1,454 shares of Korro Bio worth $154K as of Q1 2022.
  • Parametric Portfolio Associates sold 222 Korro Bio shares in Q1 2022, an estimated $42.4K.
  • Korro Bio made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3495 holding.
  • Parametric Portfolio Associates first reported a position in Korro Bio in Q1 2021 and has held it in 5 quarters since.
  • Parametric Portfolio Associates's Korro Bio position peaked at $583K in Q3 2021.
  • 85 funds tracked by Wall St. Rank held Korro Bio as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.